Immuneering Corporation (IMRX) Net margin 2020–2022
Immuneering Corporation (IMRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-15937.3%FY2022 · since FY2020: -737.2% → -15937.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -15937.3% | -14325.0 pp |
| FY2021 | -1612.3% | -875.2 pp |
| FY2020 | -737.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice